Table 3.
Major adverse cardiovascular events (MACE) by heart failure status, both pre- and post-matching.
| Major adverse cardiovascular events | Before matching |
After matching |
||||
|---|---|---|---|---|---|---|
| No HF | HF | p-Value | No HF | HF | p-Value | |
| Myocardial injury | ||||||
| Incidence (%) | 0.8 | 7.4 | – | 2.1 | 6.4 | |
| Univariable OR (95% CI) | Ref | 9.50 (4.36–22.3) | <0.001 | Ref | 3.14 (1.07–11.38) | <0.05 |
| Life-threatening arrhythmia | ||||||
| Incidence (%) | 4.7 | 12.1 | – | 8.5 | 12.2 | |
| Univariable OR (95% CI) | Ref | 2.82 (1.75–4.50) | <0.001 | Ref | 1.50 (0.77–2.98) | 0.24 |
| Deep venous thrombosis | ||||||
| Incidence (%) | 2 | 5.1 | – | 2.7 | 3.7 | |
| Univariable OR (95% CI) | Ref | 2.69 (1.29–5.38) | <0.01 | Ref | 1.42 (0.44–4.86) | 0.56 |
| HF exacerbation | ||||||
| Incidence (%) | 0.1 | 10.9 | – | 0.5 | 11.2 | |
| Univariable OR (95% CI) | Ref | 65.9 (19.6–409.9) | <0.001 | Ref | 23.51 (4.84–423.82) | <0.01 |
| Renal replacement therapy | ||||||
| Incidence (%) | 4.2 | 12.1 | – | 10.1 | 10.6 | |
| Univariable OR (95% CI) | Ref | 3.15 (1.94–5.07) | <0.001 | Ref | 1.06 (0.54–2.07) | 0.87 |
| Pulmonary embolism | ||||||
| Incidence (%) | 2.8 | 3.9 | – | 4.8 | 4.8 | |
| Univariable OR (95% CI) | Ref | 1.42 (0.65–2.84) | 0.36 | Ref | 1.00 (0.38–2.62) | 1.00 |
| Total | ||||||
| Incidence (%) | 12.2 | 29.7 | – | 22.3 | 27.7 | |
| Univariable OR (95% CI) | Ref | 3.04 (2.19–4.20) | <0.001 | Ref | 1.33 (0.83–2.13) | 0.23 |
HF = heart failure; OR = odds ratio; CI = confidence interval; Ref = reference.